Abstract: Gastric resident electronics, devices, systems, and related methods are generally provided. Some embodiments comprise administering (e.g., orally) an (electronic) resident structure to a subject (e.g., a patient) such that the (electronic) resident structure is retained at a location internal to the subject for a particular amount of time (e.g., at least about 24 hours) before exiting said location internal to the subject. In some embodiments, the resident structure is a gastric resident electronic. That is to say, in some embodiments, the resident structure is configured for relatively long gastric residence and comprises an electronic component. In some embodiments, the structures and components described herein may comprise one or more components configured for the delivery of an active substance(s) (e.g., a pharmaceutical agent) to the subject.

Abstract: A method and system for contextual heart rate monitoring are disclosed. In a first aspect, the method comprises calculating a heart rate using a detected ECG signal and detecting an activity level. In a second aspect, the system comprises a wireless sensor device coupled to a user via at least one electrode, wherein the wireless sensor device includes a processor and a memory device coupled to the processor, wherein the memory device stores an application which, when executed by the processor, causes the processor to calculate a heart rate using a detected ECG signal and to detect an activity level.

Abstract: A smart cage includes radiofrequency transceivers and tags attached to laboratory animals. The tags include sensors to detect monitorable conditions of the laboratory animals. The sensors include working electrodes, counter electrodes, reference electrodes, and potentiostats. The top surface of the electrodes is coated with ionophores or enzymes which detect the monitorable conditions of the laboratory animals.

Abstract: Some method examples may include pacing a heart with cardiac paces, sensing a physiological signal for use in detecting pace-induced phrenic nerve stimulation, performing a baseline level determination process to identify a baseline level for the sensed physiological signal, and detecting pace-induced phrenic nerve stimulation using the sensed physiological signal and the calculated baseline level. Detecting pace-induced phrenic nerve stimulation may include sampling the sensed physiological signal during each of a plurality of cardiac cycles to provide sampled signals and calculating the baseline level for the physiological signal using the sampled signals. Sampling the sensed physiological signal may include sampling the signal during a time window defined using a pace time with each of the cardiac cycles to avoid cardiac components and phrenic nerve stimulation components in the sampled signal.

Abstract: This invention is a non-invasive Brain to Computer Interface (BCI) method for interpreting a word, phrase, or command from brain activity by identifying a pattern of electromagnetic brain activity which occurs when a person uses different action modalities to communicate a word, phrase, or command. This method can enable people with neuromuscular limitations and/or paralysis to communicate. It can also enable people to communicate and/or to control environmental devices via their thought patterns in situations where communication via touch screen, keyboard, mouse, voice command, or gesture recognition is not appropriate and/or possible.

Abstract: The present application provides for use of a somatosensory evoked potential (SEP) during the hyperacute stroke phase as marker for predicting the outcome of endovascular treatment in a patient suffering from acute ischemic stroke, wherein when the SEP ipsilateral to the stroke site has an amplitude from 60% to 100% with respect to the corresponding SEP contralateral to the stroke site this is indicative of good outcome of the endovascular treatment, whereas when the SEP ipsilateral to the stroke site has an amplitude from 0% to 20% with respect to the corresponding SEP contralateral to the stroke site this is indicative of bad outcome of the endovascular treatment.

Abstract: Improved urine output collection apparatus and monitoring device features are provided. The disposable urine collection apparatus includes a collection reservoir and a diverter for controlling the flow of urine to a first passageway of the diverter in a first position and to a second passageway of the diverter in a second position, wherein the first passageway is fluidly interconnected to the collection reservoir. The disposable urine collection apparatus may include a cartridge having an internal chamber and inlet and outlet members interconnected to the cartridge, wherein the inlet member is selectively, fluidly interconnectable to the second passageway of the diverter, and wherein the outlet member is selectively, fluidly interconnectable to the collection reservoir. The monitoring device is interconnectable with the cartridge and operable to monitor a volume and/or level of urine collected within the cartridge.

Abstract: A wearable device measures heart rate recovery of a user in a non-clinical setting. The wearable device comprises a heart rate detector configured to detect heart rate data of the user, an activity sensor configured to detect motion of the user, and a processor. The processor is configured to identify a start of an activity by the user using the motion detected by the activity sensor. Responsive to detecting the start of the activity, the processor monitors the motion detected by the activity sensor to identify an end of the activity. A regression analysis is performed on heart rate data detected by the heart rate detector during a period of time after the end of the activity, and the heart rate recovery of the user is determined using the regression analysis.

Abstract: [Subject] Non-invasive method for estimating blood pressure without a cuff and a device for the blood pressure estimation [Resolution means] Systolic blood pressure (EBP) is estimated according to EBP=?1·P1+?2·P2+?0 (?1, ?2, and ?0 are coefficients) where parameter P1, which is related to pulse transit time (PTT), and parameter P2, which is related to stroke volume based on pulse waves, are variables.

Abstract: Disclosed are methods for determining physiological parameters of an individual including blood pressure, arterial compliance, flow velocity, and pressure wave velocity. A noninvasive method for determining the blood pressure of a patient is based on measurements of flow velocity, pulse wave velocity and arterial compliance. A noninvasive method for determining the arterial compliance of a patient is based on measurements of blood pressure, flow velocity, and pulse wave velocity.

Abstract: A dental appliance including a dielectric substrate with one or more electric areas having one or more integrated circuits, one or more electric lines, and optionally one or more shielding lines. The dental appliance further includes one or more ground areas including one or more ground pads, one or more sensing areas including one or more sensing pads, and optionally one or more shielding pads. The dental appliance is configured to monitor dental contact, dental forces, and/or for detecting teeth clenching and/or grinding.

Abstract: Methods, devices and system for determining fasting glucose level information and post-prandial glucose level information for diagnosing pre-diabetic and diabetic conditions based on monitored glucose measurements are provided.

Abstract: A capacitive sensing system is adapted for noninvasive measurement of blood pulse (hear rate). A capacitive sensor is located near a skin pulse point exhibiting pulse displacement of skin tissue from vascular pulsation (for example, the temple area of the head), and includes a sensor electrode disposed over and spaced from the skin pulse point, such that the distance between sensor electrode and the skin pulse point cycles between a proximal and a distal displacement distance based on vascular pulsation.

Abstract: The present invention provides a non-invasive portable device and method for diagnosing an occlusion in coronary arteries of a patient. The diagnostic system includes a signal processor configured to receive signals from a group of acoustic sensors attached to the torso of a patient. The diagnostic device is configured with a processor to receive and generate an output on a display using a high end algorithm.

Abstract: An Internet-based disease monitoring system may include a network-based disease sensor device, which is coupled to a sensor, such as a spirometer. A remote server may be coupled to the network-based disease sensor device to provide analysis of input signals from the sensor. The remote server may be able to provide various services for grouping or handling functions relating to such input signals. A service may provide the ability to aggregate input signals from multiple sensors coupled to sensor devices and provide predictive modeling or statistical analysis, which may then be used to adjust future input signals. A service may also contain instructions how to handle billing based on usage of the network-based disease sensor device.

Abstract: A method for estimating blood pressure using a blood flow occlusion system applied to an artery includes receiving from a first sensor a sensed signal; processing at a processor the sensed signal to detect beats in a pulsatile signal; determining validity of the detected beats; storing the detected beats and data associated with the detected beats in the sensed signal as the pressure applied to the artery by the blood flow occlusion system deflates towards a level below a nominal level; determining baseline beat characteristics; evaluating the stored beats and associated data to detect change in beat characteristics as compared to the baseline beat characteristics; selecting a beat before the detected change in the beat characteristic as the last beat indicating the onset of the diastolic blood pressure for the artery; determining a value of the applied pressure at the last beat as the diastolic blood pressure for the artery.

Abstract: There is provided a system for monitoring transpulmonary pressure of a mechanically ventilated individual, comprising: a feeding tube, at least one esophageal body, a pressure sensor, and a memory having stored thereon code for: computing an estimate of esophageal wall pressure according to pressure in the esophageal body when inflated and contacting the inner wall of the esophagus, computing the transpulmonary pressure of the mechanically ventilated target individual according to the esophageal wall pressure, periodically inflating and deflating the esophageal body for periodic monitoring of the transpulmonary pressure of the mechanically ventilated target patient while the feeding tube is in use, and computing instructions for adjustment of parameter(s) of a mechanical ventilator that automatically ventilates the target individual according to the computed transpulmonary pressure, wherein the instructions for adjustment of parameter(s) of the mechanical ventilator are computed while the feeding tube is in p

Abstract: Embodiments herein include implantable medical devices including chemical sensors with bioerodible masking layers to allow for staged activation of the sensors. In an embodiment, an implantable medical device includes a substrate defining wells and a first chemical sensor and a second chemical sensor disposed within separate wells of the substrate. The first chemical sensor and the second chemical sensor can be configured to detect one or more analytes. The device can include a first bioerodible masking layer disposed over the second chemical sensor, sealing off the second chemical sensor. The device can further include a protective planarization layer disposed over at least one of the first chemical sensor and the second chemical sensor such that the outermost surface of the medical device over the first sensor is flush with the outermost surface of the medical device over the second sensor. Other embodiments are also included herein.

Abstract: Transdermal microneedles continuous monitoring system is provided. The continuous system monitoring includes a substrate, a microneedle unit, a signal processing unit and a power supply unit. The microneedle unit at least comprises a first microneedle set used as a working electrode and a second microneedle set used as a reference electrode, the first and second microneedle sets arranging on the substrate. Each microneedle set comprises at least a microneedle. The first microneedle set comprises at least a sheet having a through hole on which a barbule forms at the edge. One of the sheets provides the through hole from which the barbules at the edge of the other sheets go through, and the barbules are disposed separately.

Abstract: Disclosed is a portable device for collecting and processing continuous monitoring data. The device has a data interface configured to receive a stream of continuous monitoring data from a body-worn sensor, the continuous monitoring data being indicative of an analyte in a bodily fluid. A control is connectable to the data interface. The control controls a first mode of operation during which configuration parameters are established in response to receiving a start signal indicating a sensor session start of the body-worn sensor. The control also controls a second mode of operation during which the continuous monitoring data is collected and processed and also controls the switching from the first mode to the second mode. The control blocks further starting of the first mode for a remaining sensor session time after the switching to the second mode of operation. Also disclosed are a related medical system, method and computer program product.